The Rise and Fall of Toning Shoes
There is a particular kind of product that flourishes during a specific cultural moment — promising effortless transformation, backed by breathless advertising and celebrity endorsements — only to collapse just as spectacularly under the weight of science, lawsuits, and public embarrassment. Toning shoes were precisely that kind of product. For a brief, glorious, deeply misguided window of time in the late 2000s, they were everywhere: on the feet of morning walkers, behind shop counters, in gym locker rooms, and on the bodies of supermodels in television commercials. Then they were gone. What happened to the toning shoe is a story about the fitness industry, consumer psychology, regulatory reckoning, and the eternal human desire to get something for nothing.
The Promise: A Workout with Every Step
The concept behind toning shoes was deceptively simple and brilliantly marketed. Brands like Skechers, Reebok, and MBT (Masai Barefoot Technology) claimed that their specially engineered soles — curved, unstable, or fitted with air-filled pods — would force the wearer’s body to constantly micro-correct for balance. The result, they promised, was that ordinary walking would become a miniature workout. Muscles in the legs, thighs, and notably the glutes would be engaged more deeply than with regular footwear. “Get in shape without setting foot in a gym,” ran one Skechers tagline, while Reebok’s EasyTone line promised it could help tone your legs and butt 28% more than a regular sneaker, citing internal studies conducted with laboratory equipment.
The numbers backed up the enthusiasm, at least in sales terms. Toning shoe revenue grew from roughly $17 million in 2008 to $145 million in 2009. By 2010, the market had exploded to somewhere between $1 billion and $2 billion globally. Skechers’ Shape-Ups were a particular juggernaut: chunky, cartoonishly thick-soled shoes that somehow found their way into the mainstream. Kim Kardashian filmed an ad for them. Joe Montana appeared in a Super Bowl commercial promoting Shape-Ups for men. The category attracted virtually every major athletic footwear brand at some point, including New Balance and Sketchers’ many competitors who wanted their slice of the lucrative pie.
The Science: Wobble, But No Workout
The problem was the science simply did not cooperate. As the toning shoe market boomed, independent researchers grew curious. In 2010, the American Council on Exercise (ACE) commissioned a study from the University of Wisconsin-La Crosse, asking biomechanics experts to measure whether toning shoes actually activated muscles differently from regular sneakers. The results were unambiguous and damning. Across three major brands — Skechers Shape-Ups, Reebok EasyTone, and MBT — there was no statistically significant increase in muscle activation compared to a standard athletic shoe. Not in the calves, not in the hamstrings, and certainly not in the glutes. Participants did not burn more calories. They did not tone more effectively. The shoes simply did not do what the advertising claimed.
Researchers from UNLV reached similar conclusions. A broader body of evidence began to accumulate, and it told a consistent story: the “instability principle” that underpinned toning shoe marketing was flawed. While the shoes did create a slightly different gait pattern, the human body is remarkably good at adapting — and that adaptation meant any additional muscular effort was negligible. Worse still, some studies and anecdotal reports began linking the shoes to increased rates of ankle sprains, falls, and other injuries, particularly among older wearers who were most vulnerable to the destabilising effect of rocker-bottom soles.
The Reckoning: Regulators, Refunds, and Reputational Damage
The Federal Trade Commission was paying attention. In September 2011, Reebok agreed to pay $25 million to settle FTC charges of deceptive advertising for its EasyTone and RunTone lines. The agency stated plainly that Reebok had made claims about muscle toning that were not supported by evidence, and that consumers who had purchased the shoes deserved refunds. For Reebok, a brand built on athletic credibility, it was a significant embarrassment.
Skechers followed in 2012, agreeing to a $40 million settlement with the FTC — the largest in the agency’s history for a case involving deceptive fitness claims at the time. The FTC found that Skechers had made unsupported claims about weight loss, muscle toning, and strengthening across its Shape-Ups, Resistance Runner, Toners, and Tone-Ups lines. The company had cited studies conducted by a paid Skechers consultant as though they were objective scientific research. Consumers who had purchased the shoes were entitled to submit claims for refunds, and hundreds of thousands did.
The legal reckoning did not stop there. Class action lawsuits multiplied across the country. Smaller brands quietly discontinued their toning lines. Retailers moved remaining inventory to clearance racks. The cultural mockery intensified, with the shoes becoming shorthand for the kind of wellness gimmick that preys on hopeful consumers.
The Aftermath: What We Can Learn
The toning shoe era left behind a few durable lessons. First, it demonstrated the enduring power of aspirational marketing in the fitness space. People wanted to believe that a pair of shoes could do what diet and exercise demanded real effort to achieve — and for a few years, they bought that belief in the billions. The promise was not absurd on its face; the body does compensate for instability, and there is genuine biomechanical research into unstable surfaces in rehabilitation settings. But the leap from “the body compensates” to “you’ll tone your glutes just by walking to work” was enormous, and no credible evidence ever bridged it.
Second, it showed what happens when regulatory bodies apply pressure to the fitness industry’s wildest claims. The FTC’s settlements sent a clear message to shoe companies and, more broadly, to wellness brands: extraordinary claims require extraordinary evidence. The settlements were large enough to be genuinely punishing and public enough to reshape industry behaviour.
Today, toning shoes have largely vanished from mainstream retail floors, replaced by other trends — minimalist running shoes, cushioned maximalist trainers, and the enduring popularity of athleisure. MBT still exists as a niche orthopaedic brand with a loyal following. Skechers, remarkably, recovered its reputation and continues to thrive. But the Shape-Up? The EasyTone? They are relics of a brief, strange era — a footnote in the long, colourful history of things people were briefly convinced would make them fit without really trying.
The toning shoe promised to reshape your body. Instead, it reshaped how regulators and consumers think about fitness marketing. That might be the only real workout it ever delivered.